CIK 0001582313
- Large accelerated filer
Xenon Pharmaceuticals Inc.
Sign in to watch- Ticker
- XENE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- Operating
- EIN
- 980661854
- Phone
- +1 604-484-3300
- Business address
- 200 - 3650 GILMORE WAY, BURNABY, British Columbia, Canada
- Open-market buys, last 90 days
- $1,681,140
- in 2 filings
- Open-market sales, last 90 days
- $425,829
- in 1 filing, $426K under 10b5-1 plans
Net +$1,255,311. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-09-16 | ROBIN SHERRINGTON EVP, Strategy & Innovation | Grant or award · Stock Option (Right to Buy) | +45,000 | 45,000 | ||
| 2019-09-16 | SCHELLER RICHARD H Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2019-09-16 | PIMSTONE SIMON N. CEO | Grant or award · Stock Option (Right to Buy) | +280,000 | 280,000 | ||
| 2019-09-16 | PATOU GARY Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2019-09-16 | MORTIMER IAN PRESIDENT & CFO | Grant or award · Stock Option (Right to Buy) | +135,000 | 135,000 | ||
| 2019-09-16 | HOLLER FRANK A Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2019-09-16 | Hayden Michael R Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2019-09-16 | GANNON STEVEN Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2019-09-16 | EMPFIELD JAMES R. SVP, Drug Discovery | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2019-09-16 | AYCARDI-FONSECA ERNESTO CMO | Grant or award · Stock Option (Right to Buy) | +65,000 | 65,000 | ||
| 2019-09-16 | AZAB MOHAMMAD Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2019-09-13 | AZAB MOHAMMAD Director | Sale | −23 | $9.31 | $214 | 57,561 |
| 2019-09-12 | HOLLER FRANK A Director | Exercise or conversion | +3,086 | $3.70 | $11K | 122,041 |
| 2019-09-12 | HOLLER FRANK A Director | Shares withheld for taxes | −934 | $9.38 | $9K | 121,107 |
| 2019-09-12 | HOLLER FRANK A Director | Exercise or conversion | +3,086 | $3.07 | $9K | 124,193 |
| 2019-09-12 | HOLLER FRANK A Director | Shares withheld for taxes | −934 | $9.38 | $9K | 123,259 |
| 2019-09-12 | HOLLER FRANK A Director | Exercise or conversion | +25,720 | $3.00 | $77K | 148,979 |
| 2019-09-12 | HOLLER FRANK A Director | Shares withheld for taxes | −7,781 | $9.38 | $73K | 141,198 |
| 2019-09-12 | HOLLER FRANK A Director | Exercise or conversion · Stock Option (Right to Buy) | −3,086 | 0 | ||
| 2019-09-12 | HOLLER FRANK A Director | Exercise or conversion · Stock Option (Right to Buy) | −3,086 | 0 |
Page 25 of 27 · 536 trades